Aging
Navigate
Back to articleFigure 6(6 of 6)
100%
Figure 6
Figure 6.Kaplan-Meier estimate of 12-year cancer-specific survival (CSS: A) and progression-free survival (PFS: B) of ccRCC patients according to different PTX3 serum levels at baseline.